GlassScriptPhysician profile
Hossein Eftekhari
NPI 1265694962
$9,965.52
in general payments reported to CMS, 2019-2025
26 companies · $851 in 2025
The $851 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,851 · 2020: $397 · 2021: $779 · 2022: $1,082 · 2023: $644 · 2024: $361 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,955.68 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,144.57 | 2019-2025 | Lifevest |
| Abiomed | $856.64 | 2021-2025 | Impella |
| Biotronik INC. | $852.49 | 2019-2022 | |
| Edwards Lifesciences Corporation | $351.27 | 2019-2022 | |
| Pfizer INC. | $346.70 | 2019-2023 | |
| Boston Scientific Corporation | $321.42 | 2019-2025 | Rotapro, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $292.80 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $286.65 | 2019-2023 | Camzyos |
| Sanofi-Aventis U.S. LLC | $269.72 | 2021-2023 | |
| Abbott Laboratories | $243.54 | 2019-2020 | |
| Medtronic, INC. | $234.28 | 2019-2022 | |
| Shockwave Medical, INC | $215.93 | 2025 | |
| Janssen Pharmaceuticals, INC | $109.96 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.70 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $75.06 | 2022-2023 | Assure Wcd |
| Amgen INC. | $69.31 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $56.96 | 2021-2023 | Verquvo |
| Lantheus Medical Imaging, INC. | $36.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.57 | 2020-2021 | |
| Tactile Systems Technology INC | $28.93 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $24.00 | 2023 | Evkeeza |
| Heartflow, INC. | $23.22 | 2023 | Ffrct |
| Scpharmaceuticals INC. | $21.60 | 2023 | |
| Philips North America LLC | $19.50 | 2022 | |
| Cranial Technologies, INC | $13.85 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hossein Eftekhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.